To further explore whether this enhanced communication between NPC cells via EVs promotes NPC radioresistance, a retrospective analysis of the correlation between CD63 and progression‐free survival (PFS) in NPC patients receiving IR therapy was performed. The gene discussed is CD63; the disease is nasopharyngeal carcinoma.